Associate Director / Director, Search and Evaluation - CardioVascular Disease (CVD)
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Associate Director / Director, Search and Evaluation - CardioVascular Disease (CVD) Is your heart beating for finding better treatment for cardiovascular disease? Are you curious to see new and innovative science? Would you like the opportunity to find and ensure evaluation of tomorrow’s breakthrough medicines and support the business development process leading to a potential partnership deal? Do you like to work in a dynamic environment involving external opportunities? If yes, then apply today as you might be the new Search and Evaluation colleague we are looking for! If you are a dynamic person with a proven track record of leading and managing business development processes, due diligences, or drug development projects, you should read further and consider bringing your enthusiasm and expertise to Search and Evaluation in Novo Nordisk. The position While the department is covering CVD, CKD, Liver disease and technology platforms, this position is with focus on CardioVascular Disease ( CVD). Your responsibilities in Search & Evaluation (S&E) will include, but are not limited to: Ensure strategic overview of internal, as well as BD pipeline assets and needs. Through internal and external network, explore what assets are needed for the therapy area as well as how they fit with the existing internal pipeline. Setting direction to S&E efforts within the appointed therapy/technology area. Ensure oversight of the external opportunities and internal pipeline within the designated therapy area Identification of novel pipeline assets and enabling technologies. Ensure a balanced participation in partnering events and scientific conferences. Ensure establishment and maintenance of network with potential partners. Scout for and report opportunities through professional networks or literature searches, databases or patent searches within relevant therapy areas; CVD, CKD, Metabolic dysfunction-associated steatohepatitis (MASH) and enabling technology platforms. Evaluation of novel pipeline assets and enabling technologies. Drive the technical streams of the Business Development process from strategy, to target identification as well as initial evaluation to due diligence. This is done in close collaboration with experts and stakeholders across the R&D and commercial value chain. Ensure presentations of selected opportunities to relevant stakeholders and governance boards Ensure due diligence project management, to enable decision-making. Qualifications To excel in this role, we anticipate that you bring: Master’s degree in life sciences is required Five years’ experience in R&D Business development, or equivalent R&D role Proven project management skills and experience Solid knowledge of the drug development process Experience within clinical cardiovascular drug development is an advantage Experience managing cross-functional teams, ensuring clear communication and teamwork. Ability to lead a process analyzing complex information and data to enable clear and qualified recommendations to senior stakeholders. Strong communication skills, both in written and presentation form Outgoing with networking, collaboration, and stakeholder management skills Curious, self-driven, solution-focused, and goal-oriented who functions well in a dynamic environment. About the department Search & Evaluation is part of R&D Business Development. This department leads the identification and assessment of opportunities within CVD, CKD, Metabolic dysfunction-associated steatohepatitis (MASH) and enabling technology platforms. We have colleagues in US, China and Denmark. Working at Novo Nordisk Novo Nordisk is its people. We know that life is anything but linear, and balancing what is important at different stages of our career is never easy. That’s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 50,000 employees. Together, we go further. Together, we’re life changing. Contact For further information, please contact Zaki Salanti +45 3075 2544. Deadline
02 January 2024 You do not need to attach a cover letter to your application, but please include a few lines about your motivation in your resume or CV. In addition, please avoid the use of photos in your CV. This makes for a better and more fair process. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
02 January 2024 You do not need to attach a cover letter to your application, but please include a few lines about your motivation in your resume or CV. In addition, please avoid the use of photos in your CV. This makes for a better and more fair process. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 15.12.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Søborg
Lignende jobs
-
Formuleringstekniker indenfor Solid Dosage Forms
Vil du være med til at udvikle den næste generation af nye orale lægemidler? Har du lyst til en afvekslende hverdag med gode kollegaer i en stor international virksomhed? Så grib denne mulighed for..Få mere info- Forretningsudvikler
- Måløv
-
Medical Writer (Maternity Cover)
Do you have a robust scientific background, excellent project management skills, and a passion for scientific communication? We are seeking a new skilled colleague to join our team as a Medical Wri..Få mere info- Forretningsudvikler
- Søborg
-
(Senior) Bioprocess scientists for Cell Therapy
Are you a skilled bioprocess scientist looking for an opportunity to make a difference in the lives of patients suffering from chronic diseases? Join [xxxxx]'s Cell Therapy CMC process devel..Få mere info- Forretningsudvikler
- Måløv
-
Senior Pipeline Project Manager
Få mere info- Forretningsudvikler
- København
Statistik over udbudte jobs som forretningsudviklere i Søborg
Herunder ser du udviklingen i udbudte forretningsudvikler i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Søborg over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 26. november 2024 | 16 |
| 25. november 2024 | 16 |
| 24. november 2024 | 17 |
| 23. november 2024 | 17 |
| 22. november 2024 | 17 |
| 21. november 2024 | 17 |
| 20. november 2024 | 15 |
| 19. november 2024 | 12 |
| 18. november 2024 | 10 |
| 17. november 2024 | 10 |
| 16. november 2024 | 10 |
| 15. november 2024 | 10 |
| 14. november 2024 | 10 |
| 13. november 2024 | 9 |
| 12. november 2024 | 8 |
| 11. november 2024 | 8 |
| 10. november 2024 | 7 |
| 9. november 2024 | 7 |
| 8. november 2024 | 6 |
| 7. november 2024 | 6 |
| 6. november 2024 | 6 |
| 5. november 2024 | 6 |
| 4. november 2024 | 7 |
| 3. november 2024 | 6 |
| 2. november 2024 | 6 |
| 1. november 2024 | 6 |
| 31. oktober 2024 | 8 |
| 30. oktober 2024 | 7 |
| 29. oktober 2024 | 6 |
| 28. oktober 2024 | 6 |
| 27. oktober 2024 | 7 |